Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature

BACKGROUND: Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has demonstrated effectiveness in treating ovarian, breast, and other cancers, particularly those with specific molecular subtypes including, but not limited to, BRCA1/2 mutations. Consequently, its utilization is expected to inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishimoto, Hiroshi, Sakamoto, Noriho, Kido, Takashi, Ozasa, Mutsumi, Tsutsui, Shin, Mori, Mayako, Setoguchi, Daichi, Takemoto, Shinnosuke, Obase, Yasushi, Ishimatsu, Yuji, Tomonaga, Chiharu, Matsumoto, Kanako, Morisaki, Sachiko, Miura, Kiyonori, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408235/
https://www.ncbi.nlm.nih.gov/pubmed/37553592
http://dx.doi.org/10.1186/s12890-023-02569-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408235/
https://www.ncbi.nlm.nih.gov/pubmed/37553592
http://dx.doi.org/10.1186/s12890-023-02569-3

Ejemplares similares